Equity search
Top stocks
Moje portfolio
Set Favorites, set Portfolio
Oblíbené tituly
select
NameBest
buy		Best
sell		Change
(%)
ČEZ0.24
KB0.15
PKN144.82145-0.15
Msft401.31401.4-2.52
Nokia-7.42
IBM274.87275.39-1.93
Mercedes-Benz Group AG47.705-1.34
PFE25.7325.740.44
09/06/2026 19:14:59
Real-Time data
Indices online
BUX
Further equity indices

AD index online
select
AD index online
Patria Direct
Patria DirectThings our clients appreciate most: A large and experienced team of professional brokers, customer care support, stable and secure trading platform, unique news and information service. Try our demo account and see for yourself.

Free services: Patria Plus news services, analytical reports, account opening and keeping, submitting and cancelling orders, FX conversions. Moreover, for active traders we also offer free real-time data and Investor Plus services.
 

  • 09/06/2026 19:14:22
Celldex Theraptc Rg (NASDAQ Cons)
Last trade Change (%) Change (USD) Turnover (USD)
28.72 0.56 0.16 5,133,035
R - Real-Time data can be activated by Patria Plus / Investor Plus clients HERE.

Actions
Buy / Sell - Trial portfolio
Add to my favorites
Set SMS / E-Mail alert
Analytical service
Historical data
 
  • Účetní období do: 31/12/2025
Next Economy Results
Market capitalization 2,585.19 mil. USD Hrubá marže (12M klouzavě) -
Celkové tržby (12M klouzavě) 1.55 mil. USD Návratnost vlastního jmění (ROE, 12M klouzavě) -40.62
EBITDA (12M klouzavě) -283.99 mil. USD Cena/tržby na akcii (12M klouzavě) 1,672.18
Čistý zisk pro akcionáře (12M klouzavě) -258.76 mil. USD P/E bez mimořádných položek (12M klouzavě) -
Zisk na akcii (EPS, 12M klouzavě) -3.90 P/BV (poslední čtvrtletí) 4.24
Tržby na akcii (12M klouzavě) 0.02 Enterprise Value 2,066.62 mil. USD
Účetní hodnota na akcii (BV, poslední čtvrtletí) 7.92 Cash-flow na akcii (12M klouzavě) -3.84
Hotovost na akcii (poslední čtvrtletí) 7.79 Dividenda na akcii (12M klouzavě) 0.00
Source: Reuters
Currency: USD
On mouse over for description.
  • Latest update: 11/04/2026
Financial results 
select
select
Submit
 2024/42025/12025/22025/32025/4
Cash & Equivalents2817233629
Short Term Investments697656607547490
Cash and Short Term Investments725673630583519
Accounts Receivable - Trade, Net11002
Total Receivables, Net11002
Prepaid Expenses2119182114
Total Current Assets747694648604535
Property/Plant/Equipment, Total - Net88888
Intangibles, Net2727272727
Other Long Term Assets, Total10109913
Total Assets792739692648583
Accounts Payable33241
Accrued Expenses3527304149
Notes Payable/Short Term Debt00000
Other Current Liabilities, Total12111
Total Current Liabilities4032334651
Total Long Term Debt00000
Total Debt00000
Other Liabilities, Total64445
Total Liabilities4536375056
Preferred Stock - Non Redeemable, Net0---0
Common Stock00000
Additional Paid-In Capital2,2992,3082,3182,3272,337
Retained Earnings (Accumulated Deficit)-1,555-1,609-1,666-1,733-1,814
Unrealized Gain (Loss)11111
Other Equity, Total33333
Total Equity747703655598527
Total Liabilities & Shareholders’ Equity792739692648583
Total Common Shares Outstanding6666666667
Last annual results 31/12/2025
Last interim results 31/12/2025
 
Fiscal period: Annual Fiscal period: Interim
Last fiscal year: 2025 Fiscal year: 2025
End of fiscal year: 31/12/2025 End of interim fiscal: 31/12/2025
Auditor name: PricewaterhouseCoopers LLP Period length: -
Period length: -
Source: Reuters
Currency: USD
  • Latest update: -
Basic Factors
This service is only available to Patria Plus and Investor Plus subscribers. If you are a Patria Plus or Investor Plus client, please log in.
Economy Result Estimates
This service is only available to Patria Plus and Investor Plus subscribers. If you are a Patria Plus or Investor Plus client, please log in.